Your browser doesn't support javascript.
loading
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.
Azam, Camille; Claraz, Pauline; Chevreau, Christine; Vinson, Camille; Cottura, Ewa; Mourey, Loïc; Pouessel, Damien; Guibaud, Selena; Pollet, Olivia; Le Goff, Magali; Bardies, Catherine; Pelagatti, Véronique; Canonge, Jean Marie; Puisset, Florent.
Afiliación
  • Azam C; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Claraz P; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Chevreau C; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Vinson C; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Cottura E; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Mourey L; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Pouessel D; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Guibaud S; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Pollet O; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Le Goff M; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Bardies C; Oncology department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Pelagatti V; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.
  • Canonge JM; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Centre Hospitalier Universitaire, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, France.
  • Puisset F; Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France. puisset.florent@iuct-oncopole.fr.
Eur J Clin Pharmacol ; 76(4): 579-587, 2020 Apr.
Article en En | MEDLINE | ID: mdl-31932871
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Miembro 1 de la Subfamilia B de Casetes de Unión a ATP / Inhibidores del Citocromo P-450 CYP3A / Sunitinib Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pirimidinas / Sulfonamidas / Miembro 1 de la Subfamilia B de Casetes de Unión a ATP / Inhibidores del Citocromo P-450 CYP3A / Sunitinib Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Eur J Clin Pharmacol Año: 2020 Tipo del documento: Article